Literature DB >> 8675645

Anti-inflammatory HDL becomes pro-inflammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures.

B J Van Lenten1, S Y Hama, F C de Beer, D M Stafforini, T M McIntyre, S M Prescott, B N La Du, A M Fogelman, M Navab.   

Abstract

We previously reported that high density lipoprotein (HDL) protects against the oxidative modification of low density lipoprotein (LDL) induced by artery wall cells causing these cells to produce pro-inflammatory molecules. We also reported that enzyme systems associated with HDL were responsible for this anti-inflammatory property of HDL. We now report studies comparing HDL before and during an acute phase response (APR) in both humans and a croton oil rabbit model. In rabbits, from the onset of APR the protective effect of HDL progressively decreased and was completely lost by day three. As serum amyloid A (SAA) levels in acute phase HDL (AP-HDL) increased, apo A-I levels decreased 73%. Concomitantly, paraoxonase (PON) and platelet activating factor acetylhydrolase (PAF-AH) levels in HDL declined 71 and 90%, respectively, from days one to three. After day three, there was some recovery of the protective effect of HDL. AP-HDL from human patients and rabbits but not normal or control HDL (C-HDL) exhibited increases in ceruloplasmin (CP). This increase in CP was not seen in acute phase VLDL or LDL. C-HDL incubated with purified CP and re-isolated (CP-HDL), lost its ability to inhibit LDL oxidation. Northern blot analyses demonstrated enhanced expression of MCP-1 in coculture cells treated with AP-HDL and CP-HDL compared to C-HDL. Enrichment of human AP-HDL with purified PON or PAF-AH rendered AP-HDL protective against LDL modification. We conclude that under basal conditions HDL serves an anti-inflammatory role but during APR displacement and/or exchange of proteins associated with HDL results in a pro-inflammatory molecule.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8675645      PMCID: PMC185985          DOI: 10.1172/JCI118345

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  53 in total

1.  The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum.

Authors:  R J HAVEL; H A EDER; J H BRAGDON
Journal:  J Clin Invest       Date:  1955-09       Impact factor: 14.808

2.  Ceruloplasmin. A scavenger of superoxide anion radicals.

Authors:  I M Goldstein; H B Kaplan; H S Edelson; G Weissmann
Journal:  J Biol Chem       Date:  1979-05-25       Impact factor: 5.157

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 4.  Caeruloplasmin: physiological and pathological perspectives.

Authors:  J M Gutteridge; J Stocks
Journal:  Crit Rev Clin Lab Sci       Date:  1981       Impact factor: 6.250

5.  Amyloid protein SAA is an apoprotein of mouse plasma high density lipoprotein.

Authors:  E P Benditt; N Eriksen; R H Hanson
Journal:  Proc Natl Acad Sci U S A       Date:  1979-08       Impact factor: 11.205

6.  LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture.

Authors:  J R Hessler; A L Robertson; G M Chisolm
Journal:  Atherosclerosis       Date:  1979-03       Impact factor: 5.162

7.  Dietary induced atherogenesis in swine. Morphology of the intima in prelesion stages.

Authors:  R G Gerrity; H K Naito; M Richardson; C J Schwartz
Journal:  Am J Pathol       Date:  1979-06       Impact factor: 4.307

8.  The inhibition of lipid autoxidation by human caeruloplasmin.

Authors:  D J Al-Timimi; T L Dormandy
Journal:  Biochem J       Date:  1977-11-15       Impact factor: 3.857

9.  Zinc, copper and ceruloplasmin in arteriosclerosis.

Authors:  J B Bustamante; M C Mateo; J Fernandez; B de Quiros; O O Manchado
Journal:  Biomedicine       Date:  1976-09-30

10.  Interaction of very low density lipoproteins (VLDL) with rabbit C-reactive protein.

Authors:  V G Cabana; H Gewurz; J N Siegel
Journal:  J Immunol       Date:  1982-05       Impact factor: 5.422

View more
  202 in total

Review 1.  Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.

Authors:  Martin Hersberger; Arnold von Eckardstein
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 2.  Statin effects on both low-density lipoproteins and high-density lipoproteins: is there a dual benefit?

Authors:  Kiyoko Uno; Stephen J Nicholls
Journal:  Curr Atheroscler Rep       Date:  2010-01       Impact factor: 5.113

3.  Interaction between oxidative stress and high-density lipoprotein cholesterol is associated with severity of coronary artery calcification in rheumatoid arthritis.

Authors:  Young Hee Rho; Cecilia P Chung; Annette Oeser; Joseph F Solus; Tebeb Gebretsadik; Ayumi Shintani; Paolo Raggi; Ginger L Milne; C Michael Stein
Journal:  Arthritis Care Res (Hoboken)       Date:  2010-10       Impact factor: 4.794

4.  Myeloperoxidase, inflammation, and dysfunctional high-density lipoprotein.

Authors:  Jonathan D Smith
Journal:  J Clin Lipidol       Date:  2010 Sep-Oct       Impact factor: 4.766

5.  Identification of the prooxidant site of human ceruloplasmin: a model for oxidative damage by copper bound to protein surfaces.

Authors:  C K Mukhopadhyay; B Mazumder; P F Lindley; P L Fox
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

Review 6.  Systemic lupus erythematosus and cardiovascular disease: prediction and potential for therapeutic intervention.

Authors:  Maureen McMahon; Bevra H Hahn; Brian J Skaggs
Journal:  Expert Rev Clin Immunol       Date:  2011-03       Impact factor: 4.473

7.  High-density lipoproteins are a potential therapeutic target for age-related macular degeneration.

Authors:  Una L Kelly; Daniel Grigsby; Martha A Cady; Michael Landowski; Nikolai P Skiba; Jian Liu; Alan T Remaley; Mikael Klingeborn; Catherine Bowes Rickman
Journal:  J Biol Chem       Date:  2020-07-31       Impact factor: 5.157

8.  Secretory Phospholipase A2 Is Associated with the Odds of Acute Coronary Syndromes through Elevation of Serum Amyloid-A Protein.

Authors:  Anwar Santoso; Marita Kaniawati; Syakib Bakri; Irawan Yusuf
Journal:  Int J Angiol       Date:  2013-03

Review 9.  The role of dysfunctional HDL in atherosclerosis.

Authors:  Mohamad Navab; Srinivasa T Reddy; Brian J Van Lenten; G M Anantharamaiah; Alan M Fogelman
Journal:  J Lipid Res       Date:  2008-10-27       Impact factor: 5.922

10.  HDL Mimetic Peptide Administration Improves Left Ventricular Filling and Cardiac output in Lipopolysaccharide-Treated Rats.

Authors:  Geeta Datta; Himanshu Gupta; Zhenghao Zhang; Palgunachari Mayakonda; G M Anantharamaiah; C Roger White
Journal:  J Clin Exp Cardiolog       Date:  2011-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.